[ET Net News Agency, 15 July 2025]  CSPC PHARMA (01093) rose 2.8% to HK$8.21. 
  It hits an intra-day high of HK$8.23, and an intra-day low of HK$7.95. The total shares 
traded was 61.89 million, with a value of HK$499.17m. The active buy/sell ratio is 61:39, 
with net buying turnover of HK$104.45m. J.P. MORGAN BRO (HK) accounts for greatest net  
responsive buying turnover of HK$12.74m, with volume weighted average price of HK$8.052.  
MORGAN STANLEY HK SEC accounts for greatest net responsive selling turnover of HK$21.87m, 
with volume weighted average price of HK$8.067. The stock has risen a combined 3.4% over  
the past 2 consecutive trading days.
  The Hang Seng Index now rose 39 points, or 0.2% to 24,243; the Hang Seng China  
Enterprises Index now rose 10 points, or 0.1% to 8,743. 
  
          Basic Information 
          ================= 
  
  ----------------------------------
  Nominal    8.210 % Chg     +2.75% 
  High       8.230 Low        7.950 
  Shares Tr 61.89m Turnover 499.17m 
  10-D SMA   8.038 %H.V      43.887 
  20-D SMA   7.942 VWAP       8.066 
  50-D SMA   7.394 RSI14     57.514 
  ----------------------------------
Status: Active buy/sell ratio is 61:39, with net buying turnover of HK$104.45m, rising a  
combined 3.4% over the past 2 consecutive trading days
  
Performance of stocks in the same sector or of relevance
========================================================
  
  Stock (Code)            Price (HK$) Change (%)
  ----------------------------------------------- 
  CSPC PHARMA (01093)            8.21      +2.75
  SINOPHARM (01099)             18.80      -1.78
  SINO BIOPHARM (01177)          6.28      +3.46
  INNOVENT BIO (01801)          84.55      +3.11
  WUXI BIO (02269)              26.65      -0.37
  WUXI APPTEC (02359)           89.00      +0.79
  CHINARES PHARMA (03320)        5.26      -1.13
  HANSOH PHARMA (03692)         32.85      +0.77
  BEIGENE (06160)              161.00      +5.57
  AKESO (09926)                119.00      +0.68
  ----------------------------------------------- 
  (ed)



 
 